nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP1A2—Carmustine—lymphatic system cancer	0.114	0.168	CbGbCtD
Zolpidem—CYP3A5—Teniposide—lymphatic system cancer	0.103	0.152	CbGbCtD
Zolpidem—CYP2C19—Teniposide—lymphatic system cancer	0.0829	0.122	CbGbCtD
Zolpidem—CYP2C9—Teniposide—lymphatic system cancer	0.0689	0.102	CbGbCtD
Zolpidem—CYP3A7—Vincristine—lymphatic system cancer	0.0659	0.0973	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0659	0.0973	CbGbCtD
Zolpidem—CYP3A5—Vincristine—lymphatic system cancer	0.0494	0.073	CbGbCtD
Zolpidem—CYP3A4—Cytarabine—lymphatic system cancer	0.0407	0.06	CbGbCtD
Zolpidem—CYP3A4—Teniposide—lymphatic system cancer	0.0401	0.0591	CbGbCtD
Zolpidem—CYP3A4—Mitoxantrone—lymphatic system cancer	0.028	0.0413	CbGbCtD
Zolpidem—CYP3A4—Vincristine—lymphatic system cancer	0.0193	0.0285	CbGbCtD
Zolpidem—Malnutrition—Carmustine—lymphatic system cancer	0.000497	0.00154	CcSEcCtD
Zolpidem—Cough—Bleomycin—lymphatic system cancer	0.000496	0.00154	CcSEcCtD
Zolpidem—Diarrhoea—Teniposide—lymphatic system cancer	0.000493	0.00153	CcSEcCtD
Zolpidem—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000491	0.00152	CcSEcCtD
Zolpidem—Chest pain—Bleomycin—lymphatic system cancer	0.000484	0.0015	CcSEcCtD
Zolpidem—Myalgia—Bleomycin—lymphatic system cancer	0.000484	0.0015	CcSEcCtD
Zolpidem—Back pain—Carmustine—lymphatic system cancer	0.00048	0.00149	CcSEcCtD
Zolpidem—Discomfort—Bleomycin—lymphatic system cancer	0.000479	0.00148	CcSEcCtD
Zolpidem—Mental disorder—Vincristine—lymphatic system cancer	0.000477	0.00148	CcSEcCtD
Zolpidem—Chills—Mitoxantrone—lymphatic system cancer	0.000476	0.00148	CcSEcCtD
Zolpidem—Urine output increased—Methotrexate—lymphatic system cancer	0.000476	0.00148	CcSEcCtD
Zolpidem—Bladder pain—Methotrexate—lymphatic system cancer	0.000476	0.00148	CcSEcCtD
Zolpidem—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000474	0.00147	CcSEcCtD
Zolpidem—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000468	0.00145	CcSEcCtD
Zolpidem—Confusional state—Bleomycin—lymphatic system cancer	0.000468	0.00145	CcSEcCtD
Zolpidem—Vision blurred—Carmustine—lymphatic system cancer	0.000468	0.00145	CcSEcCtD
Zolpidem—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000467	0.00145	CcSEcCtD
Zolpidem—Tremor—Carmustine—lymphatic system cancer	0.000465	0.00144	CcSEcCtD
Zolpidem—Oedema—Bleomycin—lymphatic system cancer	0.000464	0.00144	CcSEcCtD
Zolpidem—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000464	0.00144	CcSEcCtD
Zolpidem—Erythema—Mitoxantrone—lymphatic system cancer	0.000462	0.00143	CcSEcCtD
Zolpidem—Infection—Bleomycin—lymphatic system cancer	0.000461	0.00143	CcSEcCtD
Zolpidem—Anaemia—Carmustine—lymphatic system cancer	0.000459	0.00142	CcSEcCtD
Zolpidem—Back pain—Vincristine—lymphatic system cancer	0.000459	0.00142	CcSEcCtD
Zolpidem—Vomiting—Teniposide—lymphatic system cancer	0.000458	0.00142	CcSEcCtD
Zolpidem—Agitation—Carmustine—lymphatic system cancer	0.000456	0.00142	CcSEcCtD
Zolpidem—Asthenia—Fludarabine—lymphatic system cancer	0.000454	0.00141	CcSEcCtD
Zolpidem—Rash—Teniposide—lymphatic system cancer	0.000454	0.00141	CcSEcCtD
Zolpidem—Dermatitis—Teniposide—lymphatic system cancer	0.000454	0.00141	CcSEcCtD
Zolpidem—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000452	0.0014	CcSEcCtD
Zolpidem—Headache—Teniposide—lymphatic system cancer	0.000451	0.0014	CcSEcCtD
Zolpidem—Pruritus—Fludarabine—lymphatic system cancer	0.000448	0.00139	CcSEcCtD
Zolpidem—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000448	0.00139	CcSEcCtD
Zolpidem—Back pain—Mitoxantrone—lymphatic system cancer	0.000447	0.00139	CcSEcCtD
Zolpidem—Leukopenia—Carmustine—lymphatic system cancer	0.000445	0.00138	CcSEcCtD
Zolpidem—Anorexia—Bleomycin—lymphatic system cancer	0.000443	0.00137	CcSEcCtD
Zolpidem—Anaemia—Vincristine—lymphatic system cancer	0.000438	0.00136	CcSEcCtD
Zolpidem—Agitation—Vincristine—lymphatic system cancer	0.000436	0.00135	CcSEcCtD
Zolpidem—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000435	0.00135	CcSEcCtD
Zolpidem—Polyuria—Methotrexate—lymphatic system cancer	0.000435	0.00135	CcSEcCtD
Zolpidem—Hypotension—Bleomycin—lymphatic system cancer	0.000434	0.00135	CcSEcCtD
Zolpidem—Diarrhoea—Fludarabine—lymphatic system cancer	0.000433	0.00134	CcSEcCtD
Zolpidem—Hypertension—Carmustine—lymphatic system cancer	0.000429	0.00133	CcSEcCtD
Zolpidem—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000428	0.00133	CcSEcCtD
Zolpidem—Nausea—Teniposide—lymphatic system cancer	0.000428	0.00133	CcSEcCtD
Zolpidem—Anaemia—Mitoxantrone—lymphatic system cancer	0.000427	0.00132	CcSEcCtD
Zolpidem—Vertigo—Vincristine—lymphatic system cancer	0.000426	0.00132	CcSEcCtD
Zolpidem—Leukopenia—Vincristine—lymphatic system cancer	0.000424	0.00132	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000423	0.00131	CcSEcCtD
Zolpidem—Myalgia—Carmustine—lymphatic system cancer	0.000423	0.00131	CcSEcCtD
Zolpidem—Chest pain—Carmustine—lymphatic system cancer	0.000423	0.00131	CcSEcCtD
Zolpidem—Anxiety—Carmustine—lymphatic system cancer	0.000421	0.00131	CcSEcCtD
Zolpidem—Paraesthesia—Bleomycin—lymphatic system cancer	0.000417	0.00129	CcSEcCtD
Zolpidem—Malaise—Mitoxantrone—lymphatic system cancer	0.000416	0.00129	CcSEcCtD
Zolpidem—Dyspnoea—Bleomycin—lymphatic system cancer	0.000414	0.00128	CcSEcCtD
Zolpidem—Renal failure acute—Methotrexate—lymphatic system cancer	0.000414	0.00128	CcSEcCtD
Zolpidem—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000413	0.00128	CcSEcCtD
Zolpidem—Hypertension—Vincristine—lymphatic system cancer	0.000409	0.00127	CcSEcCtD
Zolpidem—Confusional state—Carmustine—lymphatic system cancer	0.000409	0.00127	CcSEcCtD
Zolpidem—Oedema—Carmustine—lymphatic system cancer	0.000405	0.00126	CcSEcCtD
Zolpidem—Decreased appetite—Bleomycin—lymphatic system cancer	0.000404	0.00125	CcSEcCtD
Zolpidem—Myalgia—Vincristine—lymphatic system cancer	0.000404	0.00125	CcSEcCtD
Zolpidem—Visual disturbance—Methotrexate—lymphatic system cancer	0.000403	0.00125	CcSEcCtD
Zolpidem—Cough—Mitoxantrone—lymphatic system cancer	0.000403	0.00125	CcSEcCtD
Zolpidem—Infection—Carmustine—lymphatic system cancer	0.000403	0.00125	CcSEcCtD
Zolpidem—Vomiting—Fludarabine—lymphatic system cancer	0.000403	0.00125	CcSEcCtD
Zolpidem—Rash—Fludarabine—lymphatic system cancer	0.000399	0.00124	CcSEcCtD
Zolpidem—Dermatitis—Fludarabine—lymphatic system cancer	0.000399	0.00124	CcSEcCtD
Zolpidem—Hypertension—Mitoxantrone—lymphatic system cancer	0.000399	0.00124	CcSEcCtD
Zolpidem—Pain—Bleomycin—lymphatic system cancer	0.000397	0.00123	CcSEcCtD
Zolpidem—Headache—Fludarabine—lymphatic system cancer	0.000397	0.00123	CcSEcCtD
Zolpidem—Tachycardia—Carmustine—lymphatic system cancer	0.000396	0.00123	CcSEcCtD
Zolpidem—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000395	0.00122	CcSEcCtD
Zolpidem—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000393	0.00122	CcSEcCtD
Zolpidem—Chest pain—Mitoxantrone—lymphatic system cancer	0.000393	0.00122	CcSEcCtD
Zolpidem—Myalgia—Mitoxantrone—lymphatic system cancer	0.000393	0.00122	CcSEcCtD
Zolpidem—Anxiety—Mitoxantrone—lymphatic system cancer	0.000392	0.00121	CcSEcCtD
Zolpidem—Lethargy—Methotrexate—lymphatic system cancer	0.00039	0.00121	CcSEcCtD
Zolpidem—Discomfort—Mitoxantrone—lymphatic system cancer	0.000388	0.0012	CcSEcCtD
Zolpidem—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000387	0.0012	CcSEcCtD
Zolpidem—Oedema—Vincristine—lymphatic system cancer	0.000387	0.0012	CcSEcCtD
Zolpidem—Anorexia—Carmustine—lymphatic system cancer	0.000386	0.0012	CcSEcCtD
Zolpidem—Infection—Vincristine—lymphatic system cancer	0.000384	0.00119	CcSEcCtD
Zolpidem—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000383	0.00119	CcSEcCtD
Zolpidem—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000382	0.00118	CcSEcCtD
Zolpidem—Confusional state—Mitoxantrone—lymphatic system cancer	0.00038	0.00118	CcSEcCtD
Zolpidem—Nervous system disorder—Vincristine—lymphatic system cancer	0.000379	0.00118	CcSEcCtD
Zolpidem—Hypotension—Carmustine—lymphatic system cancer	0.000379	0.00117	CcSEcCtD
Zolpidem—Oedema—Mitoxantrone—lymphatic system cancer	0.000377	0.00117	CcSEcCtD
Zolpidem—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000377	0.00117	CcSEcCtD
Zolpidem—Nausea—Fludarabine—lymphatic system cancer	0.000376	0.00117	CcSEcCtD
Zolpidem—Infection—Mitoxantrone—lymphatic system cancer	0.000374	0.00116	CcSEcCtD
Zolpidem—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000374	0.00116	CcSEcCtD
Zolpidem—Shock—Mitoxantrone—lymphatic system cancer	0.000371	0.00115	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000369	0.00115	CcSEcCtD
Zolpidem—Urticaria—Bleomycin—lymphatic system cancer	0.000369	0.00114	CcSEcCtD
Zolpidem—Anorexia—Vincristine—lymphatic system cancer	0.000369	0.00114	CcSEcCtD
Zolpidem—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000368	0.00114	CcSEcCtD
Zolpidem—Body temperature increased—Bleomycin—lymphatic system cancer	0.000367	0.00114	CcSEcCtD
Zolpidem—Insomnia—Carmustine—lymphatic system cancer	0.000367	0.00114	CcSEcCtD
Zolpidem—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000366	0.00114	CcSEcCtD
Zolpidem—Irritability—Methotrexate—lymphatic system cancer	0.000365	0.00113	CcSEcCtD
Zolpidem—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000364	0.00113	CcSEcCtD
Zolpidem—Paraesthesia—Carmustine—lymphatic system cancer	0.000364	0.00113	CcSEcCtD
Zolpidem—Mood swings—Methotrexate—lymphatic system cancer	0.000362	0.00112	CcSEcCtD
Zolpidem—Hypotension—Vincristine—lymphatic system cancer	0.000362	0.00112	CcSEcCtD
Zolpidem—Dyspnoea—Carmustine—lymphatic system cancer	0.000361	0.00112	CcSEcCtD
Zolpidem—Somnolence—Carmustine—lymphatic system cancer	0.00036	0.00112	CcSEcCtD
Zolpidem—Anorexia—Mitoxantrone—lymphatic system cancer	0.000359	0.00111	CcSEcCtD
Zolpidem—Ataxia—Methotrexate—lymphatic system cancer	0.000359	0.00111	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000353	0.00109	CcSEcCtD
Zolpidem—Decreased appetite—Carmustine—lymphatic system cancer	0.000352	0.00109	CcSEcCtD
Zolpidem—Hypotension—Mitoxantrone—lymphatic system cancer	0.000352	0.00109	CcSEcCtD
Zolpidem—Insomnia—Vincristine—lymphatic system cancer	0.00035	0.00109	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00035	0.00109	CcSEcCtD
Zolpidem—Paraesthesia—Vincristine—lymphatic system cancer	0.000347	0.00108	CcSEcCtD
Zolpidem—Constipation—Carmustine—lymphatic system cancer	0.000347	0.00108	CcSEcCtD
Zolpidem—Pain—Carmustine—lymphatic system cancer	0.000347	0.00108	CcSEcCtD
Zolpidem—Breast disorder—Methotrexate—lymphatic system cancer	0.000345	0.00107	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000343	0.00106	CcSEcCtD
Zolpidem—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000342	0.00106	CcSEcCtD
Zolpidem—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000338	0.00105	CcSEcCtD
Zolpidem—Decreased appetite—Vincristine—lymphatic system cancer	0.000336	0.00104	CcSEcCtD
Zolpidem—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000336	0.00104	CcSEcCtD
Zolpidem—Somnolence—Mitoxantrone—lymphatic system cancer	0.000335	0.00104	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000334	0.00104	CcSEcCtD
Zolpidem—Feeling abnormal—Carmustine—lymphatic system cancer	0.000334	0.00104	CcSEcCtD
Zolpidem—Fatigue—Vincristine—lymphatic system cancer	0.000334	0.00103	CcSEcCtD
Zolpidem—Asthenia—Bleomycin—lymphatic system cancer	0.000333	0.00103	CcSEcCtD
Zolpidem—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000332	0.00103	CcSEcCtD
Zolpidem—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000331	0.00103	CcSEcCtD
Zolpidem—Pain—Vincristine—lymphatic system cancer	0.000331	0.00103	CcSEcCtD
Zolpidem—Constipation—Vincristine—lymphatic system cancer	0.000331	0.00103	CcSEcCtD
Zolpidem—Pruritus—Bleomycin—lymphatic system cancer	0.000329	0.00102	CcSEcCtD
Zolpidem—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000328	0.00102	CcSEcCtD
Zolpidem—Fatigue—Mitoxantrone—lymphatic system cancer	0.000325	0.00101	CcSEcCtD
Zolpidem—Constipation—Mitoxantrone—lymphatic system cancer	0.000322	0.000999	CcSEcCtD
Zolpidem—Pain—Mitoxantrone—lymphatic system cancer	0.000322	0.000999	CcSEcCtD
Zolpidem—Abdominal pain—Carmustine—lymphatic system cancer	0.00032	0.000994	CcSEcCtD
Zolpidem—Body temperature increased—Carmustine—lymphatic system cancer	0.00032	0.000994	CcSEcCtD
Zolpidem—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000317	0.000982	CcSEcCtD
Zolpidem—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000316	0.000981	CcSEcCtD
Zolpidem—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000311	0.000963	CcSEcCtD
Zolpidem—Dysuria—Methotrexate—lymphatic system cancer	0.000309	0.000958	CcSEcCtD
Zolpidem—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000308	0.000956	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000307	0.000952	CcSEcCtD
Zolpidem—Body temperature increased—Vincristine—lymphatic system cancer	0.000306	0.000949	CcSEcCtD
Zolpidem—Abdominal pain—Vincristine—lymphatic system cancer	0.000306	0.000949	CcSEcCtD
Zolpidem—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000304	0.000943	CcSEcCtD
Zolpidem—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000301	0.000935	CcSEcCtD
Zolpidem—Urticaria—Mitoxantrone—lymphatic system cancer	0.000299	0.000928	CcSEcCtD
Zolpidem—Hypersensitivity—Carmustine—lymphatic system cancer	0.000299	0.000926	CcSEcCtD
Zolpidem—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000298	0.000924	CcSEcCtD
Zolpidem—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000298	0.000924	CcSEcCtD
Zolpidem—Pneumonia—Methotrexate—lymphatic system cancer	0.000296	0.000918	CcSEcCtD
Zolpidem—Vomiting—Bleomycin—lymphatic system cancer	0.000295	0.000916	CcSEcCtD
Zolpidem—Infestation NOS—Methotrexate—lymphatic system cancer	0.000294	0.000913	CcSEcCtD
Zolpidem—Infestation—Methotrexate—lymphatic system cancer	0.000294	0.000913	CcSEcCtD
Zolpidem—Drowsiness—Methotrexate—lymphatic system cancer	0.000294	0.000913	CcSEcCtD
Zolpidem—Depression—Methotrexate—lymphatic system cancer	0.000294	0.00091	CcSEcCtD
Zolpidem—Rash—Bleomycin—lymphatic system cancer	0.000293	0.000908	CcSEcCtD
Zolpidem—Dermatitis—Bleomycin—lymphatic system cancer	0.000293	0.000907	CcSEcCtD
Zolpidem—Asthenia—Carmustine—lymphatic system cancer	0.000291	0.000902	CcSEcCtD
Zolpidem—Stomatitis—Methotrexate—lymphatic system cancer	0.000287	0.00089	CcSEcCtD
Zolpidem—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000286	0.000887	CcSEcCtD
Zolpidem—Hypersensitivity—Vincristine—lymphatic system cancer	0.000285	0.000884	CcSEcCtD
Zolpidem—Epistaxis—Methotrexate—lymphatic system cancer	0.000278	0.000861	CcSEcCtD
Zolpidem—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000278	0.000861	CcSEcCtD
Zolpidem—Asthenia—Vincristine—lymphatic system cancer	0.000278	0.000861	CcSEcCtD
Zolpidem—Diarrhoea—Carmustine—lymphatic system cancer	0.000277	0.00086	CcSEcCtD
Zolpidem—Nausea—Bleomycin—lymphatic system cancer	0.000276	0.000855	CcSEcCtD
Zolpidem—Asthenia—Mitoxantrone—lymphatic system cancer	0.00027	0.000839	CcSEcCtD
Zolpidem—Dizziness—Carmustine—lymphatic system cancer	0.000268	0.000831	CcSEcCtD
Zolpidem—Diarrhoea—Vincristine—lymphatic system cancer	0.000265	0.000821	CcSEcCtD
Zolpidem—Pharyngitis—Methotrexate—lymphatic system cancer	0.000262	0.000813	CcSEcCtD
Zolpidem—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000261	0.000809	CcSEcCtD
Zolpidem—Urethral disorder—Methotrexate—lymphatic system cancer	0.000259	0.000803	CcSEcCtD
Zolpidem—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000258	0.0008	CcSEcCtD
Zolpidem—Vomiting—Carmustine—lymphatic system cancer	0.000258	0.000799	CcSEcCtD
Zolpidem—Dizziness—Vincristine—lymphatic system cancer	0.000256	0.000794	CcSEcCtD
Zolpidem—Rash—Carmustine—lymphatic system cancer	0.000256	0.000793	CcSEcCtD
Zolpidem—Dermatitis—Carmustine—lymphatic system cancer	0.000255	0.000792	CcSEcCtD
Zolpidem—Visual impairment—Methotrexate—lymphatic system cancer	0.000255	0.00079	CcSEcCtD
Zolpidem—Headache—Carmustine—lymphatic system cancer	0.000254	0.000788	CcSEcCtD
Zolpidem—Eye disorder—Methotrexate—lymphatic system cancer	0.000247	0.000766	CcSEcCtD
Zolpidem—Tinnitus—Methotrexate—lymphatic system cancer	0.000246	0.000764	CcSEcCtD
Zolpidem—Vomiting—Vincristine—lymphatic system cancer	0.000246	0.000763	CcSEcCtD
Zolpidem—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000245	0.000761	CcSEcCtD
Zolpidem—Rash—Vincristine—lymphatic system cancer	0.000244	0.000757	CcSEcCtD
Zolpidem—Dermatitis—Vincristine—lymphatic system cancer	0.000244	0.000756	CcSEcCtD
Zolpidem—Headache—Vincristine—lymphatic system cancer	0.000242	0.000752	CcSEcCtD
Zolpidem—Nausea—Carmustine—lymphatic system cancer	0.000241	0.000747	CcSEcCtD
Zolpidem—Vomiting—Mitoxantrone—lymphatic system cancer	0.00024	0.000743	CcSEcCtD
Zolpidem—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000238	0.000739	CcSEcCtD
Zolpidem—Rash—Mitoxantrone—lymphatic system cancer	0.000238	0.000737	CcSEcCtD
Zolpidem—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000237	0.000736	CcSEcCtD
Zolpidem—Chills—Methotrexate—lymphatic system cancer	0.000237	0.000735	CcSEcCtD
Zolpidem—Headache—Mitoxantrone—lymphatic system cancer	0.000236	0.000732	CcSEcCtD
Zolpidem—Mental disorder—Methotrexate—lymphatic system cancer	0.000232	0.000718	CcSEcCtD
Zolpidem—Malnutrition—Methotrexate—lymphatic system cancer	0.00023	0.000713	CcSEcCtD
Zolpidem—Erythema—Methotrexate—lymphatic system cancer	0.00023	0.000713	CcSEcCtD
Zolpidem—Nausea—Vincristine—lymphatic system cancer	0.00023	0.000713	CcSEcCtD
Zolpidem—Dysgeusia—Methotrexate—lymphatic system cancer	0.000225	0.000699	CcSEcCtD
Zolpidem—Nausea—Mitoxantrone—lymphatic system cancer	0.000224	0.000694	CcSEcCtD
Zolpidem—Back pain—Methotrexate—lymphatic system cancer	0.000223	0.00069	CcSEcCtD
Zolpidem—Vision blurred—Methotrexate—lymphatic system cancer	0.000217	0.000672	CcSEcCtD
Zolpidem—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000213	0.000662	CcSEcCtD
Zolpidem—Anaemia—Methotrexate—lymphatic system cancer	0.000213	0.000659	CcSEcCtD
Zolpidem—Malaise—Methotrexate—lymphatic system cancer	0.000207	0.000643	CcSEcCtD
Zolpidem—Vertigo—Methotrexate—lymphatic system cancer	0.000207	0.000641	CcSEcCtD
Zolpidem—Leukopenia—Methotrexate—lymphatic system cancer	0.000206	0.000639	CcSEcCtD
Zolpidem—Cough—Methotrexate—lymphatic system cancer	0.000201	0.000623	CcSEcCtD
Zolpidem—Myalgia—Methotrexate—lymphatic system cancer	0.000196	0.000607	CcSEcCtD
Zolpidem—Arthralgia—Methotrexate—lymphatic system cancer	0.000196	0.000607	CcSEcCtD
Zolpidem—Chest pain—Methotrexate—lymphatic system cancer	0.000196	0.000607	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000194	0.000603	CcSEcCtD
Zolpidem—Discomfort—Methotrexate—lymphatic system cancer	0.000194	0.0006	CcSEcCtD
Zolpidem—Confusional state—Methotrexate—lymphatic system cancer	0.000189	0.000587	CcSEcCtD
Zolpidem—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000188	0.000582	CcSEcCtD
Zolpidem—Infection—Methotrexate—lymphatic system cancer	0.000187	0.000578	CcSEcCtD
Zolpidem—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000184	0.000571	CcSEcCtD
Zolpidem—Skin disorder—Methotrexate—lymphatic system cancer	0.000182	0.000566	CcSEcCtD
Zolpidem—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000181	0.000563	CcSEcCtD
Zolpidem—Anorexia—Methotrexate—lymphatic system cancer	0.000179	0.000555	CcSEcCtD
Zolpidem—Hypotension—Methotrexate—lymphatic system cancer	0.000175	0.000544	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000171	0.000531	CcSEcCtD
Zolpidem—Insomnia—Methotrexate—lymphatic system cancer	0.00017	0.000527	CcSEcCtD
Zolpidem—Paraesthesia—Methotrexate—lymphatic system cancer	0.000169	0.000523	CcSEcCtD
Zolpidem—Dyspnoea—Methotrexate—lymphatic system cancer	0.000167	0.000519	CcSEcCtD
Zolpidem—Somnolence—Methotrexate—lymphatic system cancer	0.000167	0.000518	CcSEcCtD
Zolpidem—Dyspepsia—Methotrexate—lymphatic system cancer	0.000165	0.000513	CcSEcCtD
Zolpidem—Decreased appetite—Methotrexate—lymphatic system cancer	0.000163	0.000506	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000162	0.000503	CcSEcCtD
Zolpidem—Fatigue—Methotrexate—lymphatic system cancer	0.000162	0.000502	CcSEcCtD
Zolpidem—Pain—Methotrexate—lymphatic system cancer	0.000161	0.000498	CcSEcCtD
Zolpidem—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000155	0.00048	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000154	0.000476	CcSEcCtD
Zolpidem—Urticaria—Methotrexate—lymphatic system cancer	0.000149	0.000463	CcSEcCtD
Zolpidem—Abdominal pain—Methotrexate—lymphatic system cancer	0.000148	0.00046	CcSEcCtD
Zolpidem—Body temperature increased—Methotrexate—lymphatic system cancer	0.000148	0.00046	CcSEcCtD
Zolpidem—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000138	0.000429	CcSEcCtD
Zolpidem—Asthenia—Methotrexate—lymphatic system cancer	0.000135	0.000418	CcSEcCtD
Zolpidem—Pruritus—Methotrexate—lymphatic system cancer	0.000133	0.000412	CcSEcCtD
Zolpidem—Diarrhoea—Methotrexate—lymphatic system cancer	0.000128	0.000398	CcSEcCtD
Zolpidem—Dizziness—Methotrexate—lymphatic system cancer	0.000124	0.000385	CcSEcCtD
Zolpidem—Vomiting—Methotrexate—lymphatic system cancer	0.000119	0.00037	CcSEcCtD
Zolpidem—Rash—Methotrexate—lymphatic system cancer	0.000118	0.000367	CcSEcCtD
Zolpidem—Dermatitis—Methotrexate—lymphatic system cancer	0.000118	0.000367	CcSEcCtD
Zolpidem—Headache—Methotrexate—lymphatic system cancer	0.000118	0.000365	CcSEcCtD
Zolpidem—Nausea—Methotrexate—lymphatic system cancer	0.000112	0.000346	CcSEcCtD
